CLPT Q3 2019 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$344M

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M+62.0% YoY

Gross Profit

$2M66.4% margin

Operating Income

-$910,529-31.1% margin

Net Income

-$1M-38.4% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+12.3%

Cash Flow

Operating Cash Flow

-$964,135

Free Cash Flow

-$974,325

Stock-Based Comp.

$219,432

Balance Sheet

Total Assets

$13M

Total Liabilities

$7M

Stockholders' Equity

$6M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+62.0%
Gross Profit	$2M	$1M	+55.1%
Operating Income	-$910,529	-$1M	+24.5%
Net Income	-$1M	-$1M	+21.4%

Revenue Segments

Product Revenues

$3M44%

Functional Neurology

$2M32%

Biologics and Drug Delivery

$491,2578%

Service and Other Revenues

$333,0386%

Capital Equipment and Other

$210,5384%

Capital Equipment

$184,8253%

Biologics And Drug Delivery

$72,5001%

Therapy

$64,0951%

Therapy1Member

$50,0001%